Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.
School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
J Food Drug Anal. 2023 Dec 15;31(4):772-781. doi: 10.38212/2224-6614.3482.
The U.S. Food and Drug Administration's Sentinel System is a leading distributed data network for drug safety surveillance in the world. The National Health Insurance Research Database (NHIRD) in Taiwan was converted into the Taiwan Sentinel Data Model (TSDM) based on the Sentinel Common Data Model (SCDM) version 6.0.2. The goal of this study was to investigate the feasibility of applying the same study designs, analytic choices, and analytic tools as used by the U.S. Sentinel System to examine the same drug-outcome associations in the TSDM-formatted NHIRD. Four known drug-outcome associations previously examined by the U.S. Sentinel System were selected as the use cases: (1) use of angiotensin-converting enzyme inhibitors (ACEIs) and risk of angioedema, (2) use of warfarin and risk of gastrointestinal bleeding, (3) use of oral clindamycin and risk of Clostridioides difficile infection (CDI), and (4) use of glyburide and risk of serious hypoglycemia. We followed the same study designs and analytic choices used by the U.S. Sentinel System and applied the Sentinel Routine Querying Tools to answer the same study questions within the TSDM-formatted NHIRD. The results showed that ACEIs were associated with a non-significant increase in risk of angioedema compared to beta-blockers (hazard ratio [HR]: 1.21; 95% confidence interval [CI]: 0.89-1.64); warfarin was associated with a higher risk of gastrointestinal bleeding compared to statins (HR: 1.72; 1.50-1.98); glyburide was associated with an increased risk of hypoglycemia compared to glipizide (HR: 1.61, 1.30-2.00). We were unable to evaluate the association between oral clindamycin and risk of CDI due to the low event number. Our study demonstrated that it was feasible to directly apply the publicly available Sentinel Routine Querying Tools within the TSDM-formatted NHIRD. However, sources of heterogeneity other than design and analytic differences should be carefully considered when comparing the results between the two systems.
美国食品和药物管理局的监测系统是全球领先的药物安全监测分布式数据网络。中国台湾地区的全民健康保险研究数据库(NHIRD)基于 Sentinel 通用数据模型(SCDM)版本 6.0.2 转化为台湾监测数据模型(TSDM)。本研究旨在探讨是否可以应用与美国监测系统相同的研究设计、分析选择和分析工具来检验 TSDM 格式的 NHIRD 中相同的药物-结果关联。选择了美国监测系统之前研究过的四个已知药物-结果关联作为用例:(1)血管紧张素转换酶抑制剂(ACEIs)的使用与血管性水肿风险,(2)华法林的使用与胃肠道出血风险,(3)口服克林霉素与艰难梭菌感染(CDI)的风险,以及(4)使用格列本脲与严重低血糖的风险。我们遵循了美国监测系统使用的相同研究设计和分析选择,并应用了 Sentinel 常规查询工具来回答 TSDM 格式的 NHIRD 中的相同研究问题。结果表明,与β受体阻滞剂相比,ACEIs 与血管性水肿风险增加无显著相关性(危险比[HR]:1.21;95%置信区间[CI]:0.89-1.64);与他汀类药物相比,华法林与胃肠道出血风险增加相关(HR:1.72;1.50-1.98);与格列吡嗪相比,格列本脲与低血糖风险增加相关(HR:1.61,1.30-2.00)。由于事件数量低,我们无法评估口服克林霉素与 CDI 风险之间的关联。本研究表明,在 TSDM 格式的 NHIRD 中直接应用公开的 Sentinel 常规查询工具是可行的。然而,当比较两个系统的结果时,应该仔细考虑设计和分析差异以外的异质性来源。